跳至主要内容
临床试验/CTRI/2020/07/026401
CTRI/2020/07/026401已完成未知

Ivabradine vs beta blockers in Mitral Stenosis in Sinus Rhythm - METIVA trial

VIMSAR0 个研究点目标入组 65 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age >=18 yrs.
  • Documented/newly diagnosed mitral stenosis
  • Normal sinus rhythm (heart rate not less than 70 bpm)

排除标准

  • Unable to perform treadmill test (TMT)/contraindication for TMT/ Very severe MS in urgent need for surgical treatment
  • Other significant valvular lesions (more than mild aortic stenosis/aortic regurgitation/ mitral regurgitation/Tricuspid regurgitation/Tricuspid stenosis)
  • oPresence of significant noncardiac comorbidities, e.g., chronic obstructive pulmonary disease, renal failure, malignancy, etc.
  • RHD with Pregnancy
  • Known allergy/intolerance to study drugs
  • known coronary artery disease, cardiomyopathies, congenital heart diseases, HTN etc.
  • LVEF less than 40%
  • Marked anaemia (Hb < 8 g/dl)

研究者

发起方
VIMSAR

相似试验